|
Recent Newsletters
Interventional & Surgery: Fraud allegations | Dual-layered stents | MCS during high-risk PCI | New CAS data |
Cardiologist pays $6.75M to resolve fraud allegations | More lots of losartan recalled | $25.5B in funding |
Best of the Week: Cardiologists oppose key CMS proposals | Full-time vs. part-time physicians | Dapagliflozin & HFpEF |
Prevention & Risk Reduction: FDA issues warnings for 'fraudulent claims' | Hypertension cases skyrocket |
Updated FDA policy could help up to 1.8 million HF patients | Hydroxyurea & SCA |
Structural Heart Disease: Comparing LAA occluder devices | LAAO outcomes among women | TEER vs. surgery |
Cardiologists oppose 2 key CMS proposals | AI model could improve AVR timing |